Alpa M. Nick

6 ta ish

The University of Texas MD Anderson Cancer Center

1. Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer

   William M. Merritt, Yvonne G. Lin, Liz Y. Han +19

   Maqola20083 iqtibos

   ABIABI:AkademIndex/2026.other.332248

2. Sustained Small Interfering RNA Delivery by Mesoporous Silicon Particles

   Takemi Tanaka, Lingegowda S. Mangala, Pablo E. Vivas‐Mejía +18

   Maqola20102 iqtibos

   ABIABI:AkademIndex/2026.other.704261

3. Clinical and Biological Significance of Tissue Transglutaminase in Ovarian Carcinoma

   Jee Young Hwang, Lingegowda S. Mangala, Jansina Y. Fok +11

   Maqola20082 iqtibos

   ABIABI:AkademIndex/2026.other.704264

4. Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer

   Charles N. Landen, Blake W. Goodman, Ashwini A. Katre +11

   Maqola20102 iqtibos

   ABIABI:AkademIndex/2026.other.704268

5. c-Jun-NH2-kinase-1 Inhibition Leads to Antitumor Activity in Ovarian Cancer

   Pablo E. Vivas‐Mejía, Juliana M. Benito, Ariel Fernández +16

   Maqola20092 iqtibos

   ABIABI:AkademIndex/2026.other.704292

6. Therapeutic Targeting of ATP7B in Ovarian Carcinoma

   Lingegowda S. Mangala, Vesna Zuzel, Rosemarie Schmandt +18

   Maqola20092 iqtibos

   ABIABI:AkademIndex/2026.other.704298